Helen M. Boudreau

Insider Reports History

Entity
Individual
Location
200 Technology Square, 4 Th Floor, Cambridge, MA
Signature
/s/ David L. Klatsky, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Helen M. Boudreau:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Premier, Inc. Director Class A Common Stock 23.2K $514K $22.19 Dec 9, 2024 Direct
Cara Therapeutics, Inc. Director Common Stock 151K $113K $0.75 Jun 4, 2024 Direct
Rallybio Corp Director Option (Right to Buy) 16.5K $29.2K $1.77 May 15, 2024 Direct
Cara Therapeutics, Inc. Director Stock Option (Right to Buy) 195K Jun 4, 2024 Direct
Shattuck Labs, Inc. Director Stock Option (Right to Buy) 27.7K Jun 21, 2024 Direct

Insider Reports Filed by Helen M. Boudreau

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PINC Premier, Inc. Dec 9, 2024 1 $0 4 Dec 10, 2024 Director
STTK Shattuck Labs, Inc. Jun 21, 2024 1 $0 4 Jun 21, 2024 Director
CARA Cara Therapeutics, Inc. Jun 4, 2024 2 $0 4 Jun 6, 2024 Director
RLYB Rallybio Corp May 15, 2024 1 $0 4 May 17, 2024 Director
PINC Premier, Inc. May 15, 2024 1 -$132K 4 May 16, 2024 Director
PINC Premier, Inc. Dec 4, 2023 1 $0 4 Dec 5, 2023 Director
CARA Cara Therapeutics, Inc. Aug 2, 2023 1 $0 4 Aug 4, 2023 Director
CARA Cara Therapeutics, Inc. Aug 2, 2023 0 $0 3 Aug 4, 2023 Director
STTK Shattuck Labs, Inc. May 26, 2023 1 $0 4 May 31, 2023 Director
RLYB Rallybio Corp May 17, 2023 1 $0 4 May 19, 2023 Director
PINC Premier, Inc. Dec 5, 2022 1 $0 4 Dec 7, 2022 Director
STTK Shattuck Labs, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
RLYB Rallybio Corp May 24, 2022 1 $0 4 May 26, 2022 Director
PINC Premier, Inc. Dec 6, 2021 1 $0 4 Dec 7, 2021 Director
RLYB Rallybio Corp Jul 29, 2021 0 $0 3 Jul 29, 2021 Director
STTK Shattuck Labs, Inc. Jun 19, 2021 1 $0 4 Jun 22, 2021 Director